146 related articles for article (PubMed ID: 26024025)
21. Klotho/FGF23 Axis in CKD.
Tsuchiya K; Nagano N; Nitta K
Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
[TBL] [Abstract][Full Text] [Related]
22. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.
Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL
Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
24. Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia.
Fan Y; Liu W; Bi R; Densmore MJ; Sato T; Mannstadt M; Yuan Q; Zhou X; Olauson H; Larsson TE; Toka HR; Pollak MR; Brown EM; Lanske B
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3749-E3758. PubMed ID: 29618612
[TBL] [Abstract][Full Text] [Related]
25. An oral sorbent, AST-120, increases Klotho expression and inhibits cell senescence in the kidney of uremic rats.
Adijiang A; Niwa T
Am J Nephrol; 2010; 31(2):160-4. PubMed ID: 19955715
[TBL] [Abstract][Full Text] [Related]
26. Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification.
Gravesen E; Lerche Mace M; Nordholm A; Hofman-Bang J; Hruska K; Haagen Nielsen C; Kjær A; Olgaard K; Lewin E
PLoS One; 2018; 13(1):e0190820. PubMed ID: 29304096
[TBL] [Abstract][Full Text] [Related]
27. Metabolic acidosis inhibits soft tissue calcification in uremic rats.
Mendoza FJ; Lopez I; Montes de Oca A; Perez J; Rodriguez M; Aguilera-Tejero E
Kidney Int; 2008 Feb; 73(4):407-14. PubMed ID: 17989650
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus.
Panizo S; Naves-Díaz M; Carrillo-López N; Martínez-Arias L; Fernández-Martín JL; Ruiz-Torres MP; Cannata-Andía JB; Rodríguez I
J Am Soc Nephrol; 2016 Mar; 27(3):824-34. PubMed ID: 26187577
[TBL] [Abstract][Full Text] [Related]
29. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J
Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289
[TBL] [Abstract][Full Text] [Related]
31. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate.
Price PA; Roublick AM; Williamson MK
Kidney Int; 2006 Nov; 70(9):1577-83. PubMed ID: 16955099
[TBL] [Abstract][Full Text] [Related]
32. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
Yan J; Jingbo C; Wang D; Xie S; Yuan L; Zhong X; Hao L
Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987
[TBL] [Abstract][Full Text] [Related]
33. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
Brown AJ; Ritter CS; Knutson JC; Strugnell SA
Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
[TBL] [Abstract][Full Text] [Related]
34. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
[TBL] [Abstract][Full Text] [Related]
35. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.
Grabner A; Faul C
Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):314-24. PubMed ID: 27219043
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy.
Xie J; Wu YL; Huang CL
Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747
[TBL] [Abstract][Full Text] [Related]
37. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.
Fujii H; Yonekura Y; Nakai K; Kono K; Goto S; Nishi S
J Steroid Biochem Mol Biol; 2017 Mar; 167():55-60. PubMed ID: 27818277
[TBL] [Abstract][Full Text] [Related]
39. Tissue expression and source of circulating αKlotho.
Olauson H; Mencke R; Hillebrands JL; Larsson TE
Bone; 2017 Jul; 100():19-35. PubMed ID: 28323144
[TBL] [Abstract][Full Text] [Related]
40. Renal Klotho expression in patients with acute kidney injury is associated with the severity of the injury.
Seo MY; Yang J; Lee JY; Kim K; Kim SC; Chang H; Won NH; Kim MG; Jo SK; Cho W; Kim HK
Korean J Intern Med; 2015 Jul; 30(4):489-95. PubMed ID: 26161015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
